
Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease
Author(s) -
Erum A. Hartung,
Juan S. CalleToro,
Carolina Maya Lopera,
Jessica Wen,
Robert H Carson,
Mohini Dutt,
Kathryn Howarth,
Susan L. Furth,
Kassa Darge,
Suraj D. Serai
Publication year - 2020
Publication title -
abdominal radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.824
H-Index - 74
eISSN - 2366-004X
pISSN - 2366-0058
DOI - 10.1007/s00261-020-02694-1
Subject(s) - magnetic resonance elastography , medicine , autosomal recessive polycystic kidney disease , elastography , transient elastography , receiver operating characteristic , magnetic resonance imaging , liver disease , spleen , portal hypertension , gastroenterology , pathology , cirrhosis , radiology , autosomal dominant polycystic kidney disease , kidney , ultrasound , liver fibrosis
To evaluate whether liver and spleen magnetic resonance elastography (MRE) can measure the severity of congenital hepatic fibrosis (CHF) and portal hypertension (pHTN) in individuals with autosomal recessive polycystic kidney disease (ARPKD), and to examine correlations between liver MRE and ultrasound (US) elastography.